Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Novo launches diabetes campaign in Copenhagen

Follows introduction of ‘Cities Changing Diabetes’ programme in Mexico

Elliott Levy joins Amgen from BMS

He is appointed senior VP, global development

- PMLiVE

Alternative medicine studies criticised by researchers

Academics call to end clinical trials involving "highly implausible treatments" such as homeopathy

Easier access to medicines in the UK?

Cutting through the NICE value-based assessment consultation to find out what’s at stake

- PMLiVE

Easier access to medicines in the UK?

Cutting through the NICE value-based assessment consultation to find out what’s at stake

Exploring MINT: Part 3 – Nigeria

In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.

Inizio

- PMLiVE

Lilly’s psoriasis candidate tops Enbrel in phase III trials

Ixekizumab on course for regulatory filing in first half of 2015

- PMLiVE

Baxter ‘will file long-acting haemophilia drug by year-end’

New version of Advate clears late-stage trial

- PMLiVE

FDA approves BMS/Pfizer’s Eliquis in DVT and PE

New blood clot indication puts drug on a level with rival oral anticoagulants

- PMLiVE

Ex GSK exec to lead Sanford-Burnham

Perry Nisen appointed CEO at research institute

- PMLiVE

Omega buys pharmacy to understand customers

Will turn Warman-Freed in North London into ‘learning pharmacy’

- PMLiVE

FDA gives green light to Genzyme’s oral Gaucher drug

Oral therapy Cerdelga is set to complement intravenous Cerezyme

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links